Medisafe®

One channel converted at 28%. Another at 6%. Same patient population. Same objective. Most patient support programs ask, "Which channel should we use?" The better question is: How do you know before you send the first message? Behavioral signals identified the channel most likely to drive action, resulting in a 28% SMS conversion rate versus 6% for email. See what made the difference → https://lnkd.in/dagWAQit

How many times have you dismissed your morning alarm without thinking twice? Now imagine relying on it to manage a complex medication regimen. For many patients, that's the reality. When patient support is limited to channels that don't fit naturally into everyday life, people are left creating their own systems just to stay on track. Phone alarms. Sticky notes. Calendar reminders. Those tools may help patients remember a task, but they don't help them navigate therapy. Medication management is understanding what to expect and feeling supported throughout the journey, not just when an alarm sounds. Medisafe was built to do more than dosage reminders. From day one, patients stay connected with personalized education, adherence support, refill guidance, and timely engagement that fits into their daily lives. Support shouldn't be something patients have to create themselves. Let's rethink what patient support looks like. https://lnkd.in/e__xeeEd

Patients weren't ignoring the reminders. They just weren't receiving them through the channels they already use every day. The result? More follow-up. More outreach attempts. More work. One specialty pharma team shifted outreach to patients' preferred communication channel and reduced outreach attempts by 1.8 per patient. Read the case study → https://lnkd.in/dagWAQit

Enrollment ≠ Engagement ≠ Outcomes Elisabeth Martin explores why engagement after enrollment matters, backed by a case study that brings the impact to life.

Patient support teams can't optimize what they can't measure. With engagement being a main focus across hubs, PSPs, and digital touchpoints, teams need a clear view into what’s driving adherence, program performance, and patient outcomes. Medisafe’s real-time analytics dashboards bring these insights together, tracking adherence, engagement, and ROI with exportable reports that help teams measure impact and make informed decisions. Because effective patient support starts with knowing what’s working. Explore the Medisafe platform → https://lnkd.in/ebwB5ArT

How do you know which patients need support, what support they need, and when to intervene? Medisafe's JITI Predictive Engine automates that process by using AI and behavioral signals to identify patients at risk and deliver personalized interventions when they can have the greatest impact. The result is a lower-friction treatment journey, reduced administrative burden, and stronger patient outcomes. Explore the JITI Predictive Engine. https://lnkd.in/gkYEV-VZ

No two brands face the same engagement challenges. Medisafe's Patient Engagement Engine combines the core attributes of effective digital engagement, including: → Patient-centered experiences tailored to each therapy area → Seamless integration across the care ecosystem → Portfolio-wide scalability without sacrificing personalization → Real-world evidence and behavioral insights that prove impact The result is a platform that can be tailored to each brand while supporting an entire portfolio. Swipe through to see what effective engagement looks like in practice. Learn more at Medisafe.com

Behind every missed dose, refill, and therapy decision is a pattern. Medisafe analyzes 130+ behavioral signals per patient, including adherence trends, engagement behaviors, timing patterns, and social support factors, to identify what drives long-term persistence. Those insights have helped us uncover therapy-specific behavior patterns across dermatology, cardiovascular disease, gastroenterology, and other therapeutic areas. Explore our latest research and find the insights most relevant to your portfolio. https://lnkd.in/gArwJw_h

We're pleased to announce our partnership with AssistRx. The partnership combines AssistRx's therapy initiation and patient solutions capabilities with Medisafe's engagement platform to deliver real-time visibility, personalized interventions, and support throughout the treatment journey. The result is a more coordinated approach to patient support designed to reduce friction, improve engagement, and help patients stay on therapy. Read the full announcement. https://lnkd.in/etK2wmJB

Anyone can report on opens, clicks, and downloads. The harder question is whether patient engagement is actually changing behavior. With Medisafe, pharmaceutical teams can see how patients engage over time and how those interactions translate into adherence and persistence outcomes. When a program delivers a 95% adherence rate in the first 90 days, it's important to understand what drove it and how to replicate it. Ready to bring this level of visibility to your portfolio? https://lnkd.in/eEZKDMaT